0000899243-20-016780.txt : 20200616 0000899243-20-016780.hdr.sgml : 20200616 20200616211308 ACCESSION NUMBER: 0000899243-20-016780 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200612 FILED AS OF DATE: 20200616 DATE AS OF CHANGE: 20200616 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stueland Katherine CENTRAL INDEX KEY: 0001689575 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36847 FILM NUMBER: 20967930 MAIL ADDRESS: STREET 1: 458 BRANNAN STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94107 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Invitae Corp CENTRAL INDEX KEY: 0001501134 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 271701898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1400 16TH STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 BUSINESS PHONE: (415) 374-7782 MAIL ADDRESS: STREET 1: 1400 16TH STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 FORMER COMPANY: FORMER CONFORMED NAME: InVitae Corp DATE OF NAME CHANGE: 20121105 FORMER COMPANY: FORMER CONFORMED NAME: Locus Development Inc DATE OF NAME CHANGE: 20100910 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-06-12 0 0001501134 Invitae Corp NVTA 0001689575 Stueland Katherine C/O INVITAE CORPORATION 1400 16TH STREET SAN FRANCISCO CA 94103 0 1 0 0 Chief Commercial Officer Common Stock 2020-06-12 4 S 0 1000 16.34 D 203925 D Common Stock 2020-06-12 4 A 0 59150 0.00 A 263075 D Employee Stock Option (right to buy) 16.17 2020-06-12 4 A 0 19600 0.00 A 2030-06-12 Common Stock 19600 19600 D These sales of common stock were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 22, 2019. Includes an aggregate of 154,490 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. Shares issuable upon settlement of a restricted stock unit award that vests in three equal installments, with 1/3rd of the total award vesting on each of June 12, 2021, 2022 and 2023. Includes an aggregate of 213,640 shares of common stock issuable pursuant to restricted stock units that have not vested. Option vests over four years, with 25% of the shares vesting on June 12, 2021, and 1/48th of the remaining shares vesting monthly thereafter for the remaining three years. /s/ Thomas Brida, Attorney-in-Fact 2020-06-16